RA Capital
Laura Tadvalkar is an accomplished professional currently serving as Managing Director and Principal at RA Capital Management, L.P., with a career spanning from April 2020 to the present. In addition, Laura holds several board director positions at various biotech companies, including Hemab Therapeutics, Hyku Biosciences, Be Biopharma, Typewriter Therapeutics, and Expansion Therapeutics, among others. Laura previously served as a board observer at PepGen and has served on the board of directors for Mariana Oncology and Aliada Therapeutics, where Laura was a board chair. Academically, Laura earned a Doctor of Philosophy (Ph.D.) in Chemical Biology from Harvard University and a Bachelor of Science, cum laude, in Chemistry with distinction in the major from Yale University.
This person is not in any teams
This person is not in any offices